TransGenRx signs $30 million deal with Argentinean firm


    TransGenRx, a biotech firm that spun off of research at the LSU Ag Center, has signed a $30 million deal to produce human growth hormone for a pharmaceutical company based in Argentina. Cassara will b…

    Already an INSIDER? .

    We are glad you enjoy reading Business Report.

    Continue reading this story and get ACCESS to all our content from any device with a subscription now.

    • Get access to more than a decade of story archives.
    • Get access to our searchable data center of TOP LISTS.
    • Get exclusive content only available to INSIDERS.